BIOGEN INC. Deferred Revenue 2009-2015 | BIIB
Beta
What is deferred revenue?
Deferred revenue represents payments received in advance for goods or services that have not yet been delivered to customers.
What is BIOGEN INC.'s current deferred revenue?
BIOGEN INC. (BIIB) annual deferred revenue for 2015 was $55.7M, a 53.93% decline from 2014. BIOGEN INC. deferred revenue for the quarter ending December 31, 2015 was $55.7M.
What was BIOGEN INC.'s deferred revenue in 2014?
BIOGEN INC. annual deferred revenue for 2014 was $120.9M, a 29.99% decline from 2013.
What was BIOGEN INC.'s deferred revenue in 2013?
BIOGEN INC. annual deferred revenue for 2013 was $172.7M, a 16.69% increase from 2012.
What is BIOGEN INC.'s 5-year deferred revenue CAGR?
BIOGEN INC. deferred revenue grew at a compound annual growth rate (CAGR) of 6.16% from FY2010 to FY2015, going from $41.3M to $55.7M over 5 years.
Deferred Revenue History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR+6.2%
FY2010
$41.3M
→
FY2015
$55.7M
09101112131415
5 years selected
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →